Molecular determinants of Akt-induced keratinocyte transformation

C Segrelles1, M Moral, M Fernanda Lara

  • 1Department of Cell and Molecular Biology, CIEMAT, Madrid, Spain.

Oncogene
|October 26, 2005
PubMed

Insights

The PI3K/PTEN/Akt pathway drives cancer by increasing cell proliferation. Akt transforms keratinocytes through specific mechanisms affecting gene expression and protein translation, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The PI3K/PTEN/Akt pathway is crucial in human cancers, promoting proliferation and inhibiting apoptosis.
  • Akt signaling is a key factor in mouse skin carcinogenesis models.
  • Understanding Akt's role in keratinocyte transformation is vital for cancer therapy.

Purpose of the Study:

  • To investigate the pathways mediating Akt-induced proliferation and tumorigenesis in keratinocytes.
  • To elucidate the molecular mechanisms by which Akt transforms keratinocytes.

Main Methods:

  • Subcutaneous injection of Akt-transformed keratinocytes in mice.
  • Immunohistochemistry on mouse tumors and human oral dysplasia/head and neck squamous cell carcinoma samples.
  • Analysis of protein phosphorylation, expression, and localization.

Main Results:

  • Akt-transformed tumors showed increased Foxo3a phosphorylation but no significant changes in p21, p27, or mdm2.
  • Increased expression and nuclear localization of DeltaNp63, beta-catenin, and Lef1 were observed.
  • Elevated c-myc and CycD1 expression, linked to beta-catenin/Tcf pathway activation and mTOR signaling, were found.
  • Human cancer samples confirmed correlations between Akt activation, DeltaNp63/CycD expression, c-myc phosphorylation, and beta-catenin nuclear accumulation.

Conclusions:

  • Akt transforms keratinocytes via specific transcriptional and post-transcriptional mechanisms.
  • The study identifies DeltaNp63, beta-catenin, and mTOR as key mediators in Akt-driven keratinocyte transformation.
  • Findings highlight the PI3K/PTEN/Akt pathway as a significant therapeutic target in head and neck cancers.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...